Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of rebeccamycin analog in treating
patients who have advanced kidney cancer.